Plain-English translation of NCT05239364 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different approaches to treating a type of abnormal heart rhythm called atrial tachycardia that happens after patients have had atrial fibrillation treatment or heart surgery. Researchers will use advanced mapping technology to help guide the treatment and compare whether a standard approach or a more targeted, minimal approach works better at keeping the heart rhythm stable long-term.
After treatment for atrial fibrillation or heart surgery, some patients develop new abnormal heart rhythms that can be hard to treat and may come back even after treatment. This trial exists to find out whether using new, highly detailed mapping technology and a more focused treatment approach can improve outcomes and prevent these rhythms from returning.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo a catheter ablation procedure — a minimally invasive treatment where doctors use advanced mapping technology to identify and treat the abnormal heart rhythm. You will be randomly assigned to receive either the standard treatment approach or the newer, more targeted approach. The research team will follow up with you afterward to monitor your heart rhythm and check whether the treatment works over time.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Germany